VirExit Technologies

VirExit Technologies Current Liabilities

Current Liabilities of VirExit Technologies (VXIT) as of Nov 4, 2026.

Current Liabilities

0.00USD

Last updated:

Current Liabilities of VirExit Technologies is 2025 0.00 USD. Current Liabilities of VirExit Technologies was 2024 4.28 M USD. It decreases by % lower compared to the previous year.

The VirExit Technologies Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
3.85 M USD
Jan 1, 2019
3.63 M USD
Jan 1, 2020
3.41 M USD
Jan 1, 2021
3.02 M USD
Jan 1, 2022
3.61 M USD
Jan 1, 2023
3.95 M USD
Jan 1, 2024
4.28 M USD
Jan 1, 2025
0.00 USD
The VirExit Technologies Current Liabilities history
YEARCurrent LiabilitiesYoY
0.00USD-100.00%
4.28 MUSD+8.34%
3.95 MUSD+9.48%
3.61 MUSD+19.25%
3.02 MUSD-11.41%
3.41 MUSD-5.98%
3.63 MUSD-5.59%
3.85 MUSD+64.90%
2.33 MUSD+67.70%
1.39 MUSD+224.34%
428,716.00USD+2,908.96%
14,248.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

VirExit Technologies Stock analysis

What does VirExit Technologies do? VirExit Technologies, Inc. generates revenue through its branded products and services, including disinfectant cleaners, antiviral medications, personal protective equipment (PPE), and sterilization systems under the VirExit(r) and VirExit.com brands. The company targets buyers seeking protective solutions for individual, community, and local economic needs in rural and peri-urban areas globally. Its Lexian product, an Ultraviolet-C-based device, is marketed as a sterilization system for disabling viruses and bacteria through optical diffusion. The firm operates a vertical online marketplace as a primary sales and marketing platform, connecting buyers and sellers of protective products and services. This platform serves as a single source for customers requiring disinfectants, medications, PPE, and sterilization systems. VirExit(r) and VirExit.com are the key brands driving product visibility and sales across its target segments. VirExit Technologies focuses on rural and peri-urban markets worldwide, where it incubates franchise business concepts to support local economies. The company's offerings are designed to address health and safety needs, with Lexian positioned as a specialized sterilization solution. Its business model integrates product sales, franchise incubation, and an online marketplace to serve both individual and community-level demand. VirExit Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about VirExit Technologies stock

On Eulerpool you can find the complete historical development of Current Liabilities VirExit Technologies since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's VirExit Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — VirExit Technologies

All Key Metrics — VirExit Technologies